A detailed history of Quarry LP transactions in Novo Cure LTD stock. As of the latest transaction made, Quarry LP holds 1,561 shares of NVCR stock, worth $25,147. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,561
Previous 1,172 33.19%
Holding current value
$25,147
Previous $20.1 Million 21.53%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.61 - $23.34 $6,072 - $9,079
389 Added 33.19%
1,561 $24.4 Million
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $9,558 - $19,432
-808 Reduced 40.81%
1,172 $20.1 Million
Q1 2024

May 15, 2024

BUY
$12.42 - $17.29 $9,662 - $13,451
778 Added 64.73%
1,980 $30.9 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $13,378 - $18,967
1,202 New
1,202 $17.9 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.69B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.